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Abstract 
 
Folate is essential for human health in the prevention of megaloblastic anaemia 
and neural tube birth defects as well as roles in cardiovascular disease and 
cancer. Therefore research into environmental factors that may impact folate 
status, such as solar ultraviolet radiation, is of great health significance. In vitro 
studies have shown that ultraviolet (UV) radiation can degrade folate and folic 
acid in human blood and this has been confirmed in several human studies. 
Despite these findings, there is a dearth of epidemiological research into 
investigating the relationship between folate status and the links to solar UV 
exposure.  
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Introduction 
 
Folate is a water soluble B-vitamin that plays an important role in human health. 
Classically, folate deficiency is associated with an increased risk of neural tube 
birth defects (such as spina bifida) and megaloblastic anaemia1,2. Low folate 
status may also be a risk factor for some cancers and cardiovascular disease, 
although the role of folate in these diseases is a controversial topic with studies 
showing conflicting results3-7. The health impacts of low folate status necessitate 
the investigation of possible determinants of folate status, this research being 
especially important for populations most vulnerable to folate deficiency such as 
pregnant women and the elderly. One little known factor which may potentially 
decrease folate status is exposure to solar ultraviolet (UV) radiation, with 
research showing that UV radiation has the capacity to degrade folate in human 
blood and skin8,9. The relationship between UV radiation and folate degradation 
is complicated by the fact that UVB (Ultraviolet B, 280-315nm) radiation, while 
being able to degrade the main biological form of folate found in blood, 5-
Methyltetrahydrofolate (5MTHF), is unable to penetrate to the dermal circulation 
to impact blood levels10,11. The longer wavelength UVA (Ultraviolet A, 315-
400nm) is able to penetrate to the dermal circulation but is unable to directly 
degrade 5MTHF10. The recent discovery of an indirect degradation pathway via 
UVA derived generation of Reactive Oxygen Species (ROS) able to oxidise and 
therefore indirectly degrade 5MTHF, has however, led to renewed interest in the 
field10-13. Other mechanisms such as the direct degradation of the synthetic form 
of folate, folic acid in the blood by UVA and the effect of folate depletion in the 
skin from chronic UV exposure are also important pathways that appear to 
impact folate status in humans9,14. The public health consequences of solar UV 
induced degradation of folate in humans have the potential to be enormous, 
especially in a country such as Australia, which has high annual UV exposures15. 
Despite in vitro findings showing UV’s role in the degradation of folates in the 
human body, there is a dearth of population based research in this potentially 
important area. In this review, we will provide an investigation of the major 
research findings in the area of UV and folate, with a particular focus on in vivo 
research and discuss the strengths and weaknesses of the major studies 
conducted in this important field. We will also identify existing gaps in the 
research and provide recommendations for possible future studies in UV and its 
impact of folate status. 
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Folate  
 
Folate is obtained exclusively from dietary intake or supplementation16. Via the 
small intestine, folate enters the circulation and is absorbed by cells where it is 
converted to active forms such as  5MTHF17. In its active tetrahydrofolate forms, 
its role as a one-carbon carrier is essential in methylation reactions, which 
include DNA synthesis (for a more detailed treatment of folate metabolism and 
forms please refer to Ulrich et al. 20087)16. Folate in food primarily exists in 
polyglutamate forms with leafy green vegetables being a rich source of folate, 
however other fruit and vegetables such as broccoli, cauliflower and oranges are 
good sources, and liver, yeast and beer also provide a source of folate18. The 
synthetic form of folate used in (the majority of) supplements and food 
fortification is folic acid (also known as pteroylmonoglutamic acid or PGA), as this 
form has greater bioavailability and stability than the natural folates found in 
foods16. Folic acid is reduced to the active 5MTHF form, however high doses 
(>200 µg) result in the appearance of unmetabolised folic acid in the bloodstream 
before its conversion to 5MTHF19. To account for differences in higher 
bioavailability of folic acid compared to food folate, the Dietary Folate Equivalents 
(DFE) have been developed where 1 DFE = 1 µg food folate, or 0.6 µg folic acid 
added to food as a fortificant or 0.5 µg of folic acid taken as a supplement when 
fasting14,20.  Many countries fortify foods with folic acid, for example, fortification 
of flour has been mandatory in the United States and Canada since 1998 and 
other countries such as Australia have also followed and introduced mandatory 
folic acid fortification recently21,22. The National Institutes of Health (NIH) in the 
United States have set the Recommended Daily Intake (RDI) for folate at 400 µg 
a day for adults with higher levels of 600 µg/day recommended for pregnant 
women to reduce the risk of neural tube defects23. Table 1 provides a summary 
of the folate content (as DFE) of selected foods and multivitamin supplements. 
 
Health implications of folate status 
 
Low serum folate levels, caused by either an inadequate dietary intake or 
conditions such as malabsorption or liver disease, are classically associated with 
the development of megaloblastic (large cell type) anemia and, in fetuses of 
folate deficient mothers, neural tube defects (NTD’s) such as spina bifida1,2. 
Indeed it is the prevention of NTD’s, particularly following the landmark Medical 
Research Council’s (MRC) vitamin study which showed folic acid 
supplementation reduced NTD risk by 72% (95% CI: 0.12-0.71) in pregnant 
women when taken before and following conception, that has led many countries 
to introduce the folic acid fortification in foods described above21,22,25.  
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As folate plays an important role in the metabolism of the amino acid 
homocysteine, which is classified as an independent risk factor for cardiovascular 
disease, there has been much research interest in the role of folate for reducing 
cardiovascular disease risk via the lowering of total homocysteine levels in the 
blood16. Early studies with folic acid supplementation showed much promise by 
significantly lowering homocysteine levels while observational studies reported 
significant increases in cardiovascular risk in as a result of elevated 
homocysteine 3,26.  More recent data from randomized control trials has however 
consistently shown a null effect from folate and other B vitamins on 
cardiovascular disease risk; for instance, results from a recent large meta-
analysis (eight trials composed of 37,485 participants) show that homocysteine 
lowering intervention via vitamin B supplementation (including folate) had no 
statistically significant effects on cardiovascular disease risk or mortality4,6. To 
explain this null effect shown by the casual evidence, Blum and Smulders27 have 
proposed an interesting hypothesis suggesting that the high levels of folic acid 
supplementation used in homocysteine lowering trials may lead to increased 
inflammation and proliferation, stimulating atherosclerotic plaque growth and 
destabilization. This would have the effect of negating any improvements in 
cardiovascular disease risk from lowering homocysteine levels.  
 
Folate’s essential role in DNA synthesis and repair has also made its role in 
cancer carcinogenesis of great research interest, with folate appearing to provide 
a protective effect on some cancers (eg. colorectal) early in carcinogenesis7. For 
example, a large prospective analysis of cancer mortality and morbidity in 
Western Australia (N=1,988) showed independent associations between 
decreased folate levels and increased risk of prostate cancer mortality and breast 
cancer morbidity over 20 years of follow up28. While adequate folate is essential 
to human health there is increasing focus also on the health effects of excess 
folate particularly in its folic acid form. The ability of folic acid to mask the 
haematological signs of vitamin B12 deficiency is a major concern as this can 
lead to a missed diagnosis and the progression of the neurological damage 
associated with vitamin B12 deficiency29. There is also some evidence that too 
much folic acid may increase risk of some cancers, for example, results from the 
Prostate, Lung, Colorectal and Ovarian (PLCO) screening trial showed a 20% 
increased risk in breast cancer development in females taking >400 µg/day of 
folic acid supplements compared to those not taking supplements30. Several 
other studies have also shown possible deleterious effects of folic acid 
supplementation on colon and prostate cancer, although there is a lack of 
consensus and evidence remains mixed in this area31,32. While the exact 
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mechanisms for the apparent dual health effect for folate on cancer are unknown, 
folate, through its role in DNA synthesis and repair, is thought to protect against 
cancer initiation, but once preneoplastic tumors become established, it may aid 
the progression of cancer29. It is important to note that even high intakes of 
natural folates found in food are rarely, if ever, implicated in increased cancer 
risk, however the paucity of quantitative folate intake data from diet makes any 
conclusion regarding the different health effects of folate from food versus folic 
acid difficult 29. While there is a lack of consensus in this area, the growth of 
mandatory food fortification with folic acid makes further research into the 
possible health risks of folic acid essential.  
 
For determining folate status, the following pathological tests are used: serum 
folate and erythrocyte folate. Serum folate provides a short-term assessment of 
folate status and thus is determinant of recent folate intake, while erythrocyte 
folate, provides a longer-term assessment of folate status (past 2-3 months 
intake)18. Traditionally, immunoassay methods are used to test folate status, 
however this technique is unable to distinguish between the different folate 
metabolites and detect the presence of unmetabolised folic acid in the circulation, 
thus High Performance Liquid Chromatography (HPLC) is needed when data on 
specific forms of folate are required19,33. The Royal College of Pathologists of 
Australasia uses reference ranges of 7-45 nmol/L for serum folate and 360-1400  
nmol/L for erythrocyte folate, to define normal folate status34. However, both 
erythrocyte and serum folate status cutoffs for deficiency are poorly defined for 
health outcomes and various researchers have used different cutoff levels to 
define deficiency or ‘low’ folate status 1,17. An example of various cutoffs to define 
low serum and erythrocyte folate is provided in Table 21. 
 
Folate and Ultraviolet Radiation: Overview 
 
With folate’s role in many aspects of human health, environmental factors that 
may affect folate status are of great interest from a health perspective. One of 
these environmental factors is the photosensitivity of folates upon exposure to 
UV radiation. While there has been a recent upsurge of research conducted in 
the area of UV induced folate degradation, interest in this area is not a recent 
phenomenon, with Branda and Eaton35 µproposing a relationship between UV 
sun exposure and the evolution of human skin colour in 1978. Branda and 
Eaton35 proposed that maintenance of genetic characteristics such as dark skin 
colour requires continuous positive selection, therefore there must be strong 
evolutionary pressures favoring retention of highly melanised skin in areas of 
intense solar radiation. The hypothesis is based on the observation that 
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populations with more heavily melanised skin evolved close to equatorial areas 
as darker skin provided these populations with a survival advantage by reducing 
folate and possibly other nutrient photodegradation by solar UV exposure36. 
Other explanations for the retention of dark skin colour, such as the protection 
that dark skin provides against the carcinogenic effects of UV are likely not to 
have impacted reproduction and therefore selection, while micronutrient 
deficiencies, particularly folate, are known to play essential roles in fetal 
development and fertility and are therefore a much  more likely to drive selection 
pressures35. Since the publication of this article, several other authors have also 
published papers supporting the theory of the photoprotective role of melanised 
skin to reduce micronutrient degradation and its resulting impact on the evolution 
of human skin colour36-39. Similarly, it has been hypothesized that lighter skin 
provided a survival advantage away from the equator at higher latitudes, in this 
case by improving UV induced vitamin D synthesis, which is reduced in more 
heavily melanised populations40.  
 
Folate and Ultraviolet Radiation: Laboratory studies 
 
Several experimental studies have proven that folate is vulnerable to UV 
degradation. For instance, in vitro studies have shown that folic acid (the 
synthetic form of folate) is photosensitive to UVA radiation13,41-45. These studies 
have shown that when folic acid is exposed to UVA, it undergoes photolysis and 
is cleaved into several photoproducts44.  Laboratory studies have also shown that 
biological metabolites of folate found in the human body such as 5MTHF are 
sensitive to UVB (280-320 nm) radiation, but not UVA (320-400 nm)10. Figure 1 
illustrates this by showing the absorbances of both 5MTHF and folic acid when 
exposed to different UV wavelengths, both UVA and UVB are absorbed by folic 
acid and UVB is absorbed readily by 5MTHF, however absorbance in the UVA 
spectrum by 5MTHF is minimal46. UVC (Ultraviolet C, 100-280 nm) radiation is 
absorbed by both folic acid and 5MTHF, although as it is absorbed by the earth’s 
atmosphere it does not reach the earth’s surface to affect the skin10. Thus from 
absorbances alone, UVB would appear to be the main UV wavelength 
responsible for folate degradation. This, however, does not take into account the 
fact that UVB does not penetrate deeply enough into the skin to reach the dermal 
circulation and is therefore unlikely to influence blood folate levels directly10. The 
longer wavelength UVA, although able to penetrate the skin to a greater depth 
and reach the dermal circulation, is unable to directly degrade 5MTHF, resulting 
in the inability of solar UV radiation to directly impact 5MTHF levels in blood14.  
 
The recent discovery of photosensitisers such as flavins and porphyrins that 
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have the ability to indirectly degrade 5MTHF during UV exposure has however 
provided a biologically plausible mechanism for in vivo UV degradation of 
folate11,12. Both flavins and porphyrins are natural photosensitisers in human 
blood which produce reactive oxygen species (ROS), such as singlet oxygen, 
when exposed to UV radiation11,12. It is the production of these ROS that has 
been proposed as a mechanism that leads to the degradation of 5MTHF to the 
oxidized inactive form methyl 5,6 dihydrofolate12. As UVB radiation will not 
penetrate deeply enough into the dermis to affect circulating photosensitisers, it 
is proposed that it is UVA that indirectly degrades 5MTHF through the generation 
ROS (particularly singlet oxygen) from photosensitisers (See Figure 2 for role of 
UVA in folate degradation)12. Thus, combined with laboratory studies showing 
direct degradation of folic acid by UVA, this discovery provides a second, indirect 
mechanism whereby can UVA potentially degrade folate, although 
epidemiological studies are needed to confirm whether UV radiation in vivo via 
sun exposure or sunbeds can significantly decrease folate levels in humans. 
 
While most of the few studies in the area are focused on blood levels of folate, 
folate levels in the skin are particularly vulnerable to degradation by ultraviolet 
radiation, both via direct photodegradation and indirect degradation via ROS 9,47. 
The depletion of folate in skin may have significant health impacts; for instance, 
Williams et al.9 recently conducted an experiment with a cultured keratinocyte cell 
model, showing that keratinocytes depleted of folate had a decreased capacity to 
repair DNA damage when exposed to solar simulated light.  Thus folate depletion 
in the skin, combined with UVR exposure, appears to favor the development of 
the genomic instability associated with early skin carcinogenesis, a situation 
which was shown to be reversed by the addition of  folate (in the form of folic 
acid) to keratinocytes which  reestablished repair of DNA damage  in these cells9. 
While the capacity of UV radiation to damage skin is not a new concept, the 
direct role of UV radiation in the degradation of folate in the skin and the 
observation of enhanced photo-and-oxidative damage in folate depleted cells 
requires much further investigation. The increased skin folate repletion demands 
caused by intense UV radiation exposure may also be another pathway leading 
to depletion of circulatory folate as blood folate needs to replete lost folate in the 
skin (see Figure 2). Further research into UV induced folate depletion of skin is 
therefore needed to further our knowledge of its role in carcinogenesis and the 
potential for decreasing circulatory folate. 
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Folate and Ultraviolet Radiation: Seasonal evidence 
 
There have been a number of ecological studies that have shown seasonal 
variation between folate levels, with lower serum folate and or erythrocyte folate 
reported during summer or spring compared to winter and autumn seasons 
where UV exposure is less48-50. Research has also shown seasonality differences 
in NTD’s, with lower levels of NTD’s reported during winter (higher serum folate) 
compared to summer (lower serum folate)50. Seasonality differences in cancer 
diagnosis and mortality have also been the focus of recent folate research46. As 
reported earlier, higher folate status appears to be protective in early stages of 
carcinogenesis, however higher folate status during later stages of 
carcinogenesis may decrease cancer survivability for some types of cancer29,46.  
Indeed, inhibition of folate metabolism plays a major role in cancer treatment with 
the use of chemotherapeutic agents such as methotrexate in cancer therapy51. It 
is through the theory of lower folate status possibly improving cancer survival at 
certain stages in carcinogenesis, that Steindal et al.46 has proposed the 
hypothesis that cancer mortality is linked to seasonality via UV’s role in folate 
photodegradation. For instance, several Norwegian studies have shown that the 
relative risk of death for some cancers was 20-50% lower for cases if diagnosed 
in summer, compared with winter (after 18 months of follow-up)51-54. Steindal et 
al.46 suggests that lower folate status in summer resulting from increased solar 
UV folate degradation is a possible reason for the improved cancer prognosis 
seen in these studies. While these studies were primarily investigating the role of 
vitamin D and seasonality in cancer prognosis, the Norwegian data provides an 
interesting alternative hypothesis, particularly considering folate’s important role 
in cancer. It is also important to consider that both hypotheses are not mutually 
exclusive; for instance, both higher vitamin D and lower folate status in summer 
may contribute to the improved cancer prognosis seen in ecological research 
designs. Further investigation in this important area is therefore needed into how 
solar induced degradation of blood folate may be a factor in improving prognosis 
in some forms of cancer or preneoplastic tumors. 
 
Folate and Ultraviolet Radiation: Sunbed and Solar Ultraviolet studies 
 
There have only been a few small population-based studies conducted into UV 
induced folate degradation (See Table 3). These include a study Gambichler et 
al.55 showing that both single and serial exposure to UVA radiation via a sunbed 
did not significantly affect serum folate levels in healthy participants. Small study 
numbers (N=24; with only eight volunteers exposed to UVA radiation) and the 
use of UVA radiation, which is not able to photodegrade 5MTHF-the main form of 
  9
circulatory folate in the human body may have impacted the results. While the 
study undertaken by Gambichler et al.55 agrees with the laboratory data showing 
that 5MTHF is not vulnerable to direct photodegradation by UVA (although some 
indirect degradation may have been expected), other forms of folate may be 
more susceptible. For instance, the finding that folic acid is sensitive to UVA 
irradiation is extremely important due to the use of this form for supplementation 
and food fortification. The findings from in vitro studies reported earlier, showing 
higher UVA absorption in folic acid compared to 5MTHF, led Fukuwatari et al.14 
to hypothesise that humans taking folic acid supplements would be at increased 
risk to degradation of folate by sunlight (via UVA exposure).  To test this 
hypothesis, a series of experiments were conducted using a sample of Japanese 
college students aged between 21-24 who were asked to bathe in sunlight 
between 11am to 1pm, while also taking 0.25 mg of folic acid supplements at 
each meal for two days prior to, and once on the day of blood testing14. Folate 
concentrations were decreased when participants (n=7) bathed in sunlight, while 
when participants were not exposed to sunlight, folate concentrations remained 
the same (for participants exposed: plasma folate pre-test =38.0+7.2 nmol/L vs. 
post-test =28.1+4.6 nmol/L)14.  The studies also showed no difference in plasma 
folate post sun exposure when folic acid was not taken as supplements by 
participants. This corresponds to the data collected by Gambichler et al.55 and in 
vitro studies showing no significant absorption and degradation of 5MTHF by 
UVA irradiation. While there are several limitations in the study by Fukuwatari et 
al.14, particularly the small study numbers and lack of randomisation, data 
collected from the study points to the possibility that people supplementing with 
folic acid are at greater risk of folate degradation than those who are not. This is 
of particular concern for pregnant women (especially with high sun exposure) 
who often obtain a significant proportion of their folate intake from folic acid 
supplementation16. The data from both of these studies also raises questions 
about the degree of the in vivo impact of indirect degradation of 5MTHF via 
generation of ROS, as they showed no significant change in folate status 
following UV exposure (with the exception of the significant change if folic acid 
was taken)14,55.   
 
Several studies have also examined the effect of UVB radiation exposure on 
folate status by using psoriasis patients where UVB radiation therapy is often 
used as a treatment56. Narrowband UVB phototherapy was used to investigate 
the effect of UVB on serum and erythrocyte folate status in patients with psoriasis 
by Rose et al.57 (N=35); and in a mixed sample of dermatological patients by 
Cicarma et al.58 (N=19), although no effect was observed in either of these 
studies. An earlier study by Shaheen et al.59, however reported a significant 27% 
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decrease in serum folate following exposure of 20 vitiligo patients to 36 
narrowband UVB sessions. All three studies used similar equipment with the 
UVB source provided by standard narrowband UVB bulbs (Philips TL-01 
fluorescent lamps) which have an emission peak of 311 nm. One likely 
explanation for the differences is the larger number of phototherapy sessions and 
higher cumulative UVB exposure used in the Shaheen et al.59 study to treat the 
exposure group60. It is also worth noting the different types of dermatological 
conditions used in each these studies may have also affected results, however 
little research is available into how any these conditions may impact vulnerability 
of folate to ultraviolet radiation.  
 
To test the effect of broadband UVB exposure (280-400 nm), a recent study was 
conducted by Juzeniene et al.33 in which both erythrocyte and serum folate were 
measured via a series of experiments in both healthy volunteers and psoriasis 
patients in Oslo, Norway. Both broadband UVB exposure from sunbeds and 
sunlight exposure during summer were shown to have no influence on healthy 
participants, however a small decrease in folate level was observed in psoriasis 
patients following broadband UVB exposure33.  Once again small study numbers 
(N= 5 to 13) and the lack of measurement of dietary and supplemental folate 
intake (to allow controlling for) in the sample are some limitations. Also, as noted 
by Juzeniene et al.33, the use of HPLC rather than the more standard 
immunoassay method for analysing erythrocyte folate would have allowed the 
observation how UVB and sunlight affected different folate fractions such as 
5MTHF, folic acid and the oxidised methyl 5,6 dihydrofolate. This study, 
combined with previous research, is important as it provides evidence that only 
very high doses of UVB are required to photodegrade 5MTHF. As UVB is unable 
to penetrate to the dermal circulation it is possible that skin derived depletion of 
folate (see figure 2) or possibly another mechanism; for instance, an increased 
vulnerability to UVB in people with some dermatological conditions is responsible 
for this degradation.     
 
With so few epidemiological studies conducted, the ability of sun exposure to 
affect folate status in clinically significant levels, that would impact human 
disease, is impossible to ascertain. There is also conjecture as to whether UV 
sun exposure’s impact on folate status would have provided the necessary 
selection pressure to provide a role in the evolution of human skin colour. 
Research in countries with higher UV intensities and exposures may be an 
important next step, as most of the epidemiological research has been conducted 
in higher latitudes where UV intensities even in summer are quite low.  
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Conclusion 
 
The question of whether UV radiation can affect folate status in clinically 
significant levels in vivo is of great health importance. While laboratory findings 
have allowed us to elucidate possible mechanisms of UV induced folate 
degradation and ecological studies have pointed to possible health effects from 
UV induced folate degradation, in vivo data has shown mixed results. Population-
based studies have mainly focused on the use of sunbeds with only a few studies 
testing the impact of solar UV exposure on folate status. Further complicating 
matters is the lack of consensus regarding folate reference ranges and the need 
to measure different types of folate due to the varied impacts of UVA and UVB 
radiation on the different forms of folate, such as 5MTHF and folic acid. However, 
recent findings showing UV photodegradation of the synthetic folic acid in vivo 
when people are exposed to solar UV is of great health significance due to the 
introduction of mandatory folic acid fortification in food for many countries and the 
reliance, particularly of pregnant women, on folic acid supplementation to provide 
a significant proportion of their folate needs.  
 
Larger epidemiological studies are really needed that will allow researchers to 
observe the effects of UV on the folate status of free-living individuals. These 
larger studies would build on the research already conducted in this area and 
would enable researchers to observe any statistically significant population level 
affects between solar UV exposure and folate status. This, combined with a 
research emphasis on groups who are most vulnerable to folate deficiency, for 
example, pregnant women taking folic acid supplements, would provide much 
needed data into the possible consequences of folate photodegradation on 
human health. Improving our understanding of the various mechanisms of UV 
induced folate degradation in blood will also be important as this would allow the 
elucidation of the relative contributions of direct and indirect UVA mechanisms of 
photodepletion of folate. The impact of folate depletion in the skin by both UVA 
and UVB radiation and its impact on skin cancer as well as contribution to 
decreased blood folate status via increased skin folate demands is another area 
of folate research in need of further investigation.  
Future studies need to consider appropriate folate assay methodology as 
research has shown varying impacts of UV radiation on different forms of folate 
For instance, much of the current research has focused on measurement of 
blood levels of 5MTHF, while other important metabolites such as folic acid, 
which is more vulnerable to UVA degradation, are rarely tested or not 
distinguished in standard serum folate and erythrocyte folate assays. Thus the 
use of assays which allow researchers to distinguish between different folate 
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metabolites will be important. Another important consideration is that so far much 
of the interest and conduct of folate and UV research has been largely confined 
to Northern Europe and Japan, regions where populations experience 
significantly less UV exposure than countries such as Australia, so research into 
the effects of sunlight exposure on the folate status of populations in high UV 
environments is a priority. Future research into this field will also benefit greatly if 
dietary and supplemental folate intake is also collected, as both the type and 
amount of folate consumed have major implications for UV and folate studies. 
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Table: 1 Dietary Folate Equivalents (DFE’s) of selected foods and supplements 
 
Food DFE’s  (µg) per 100g Weight/serving to provide RDI 
(400 µg/day) 
 
Wholemeal Bread 
(fortified-Australia) 
248 160g (approx. 5 slices) 
Asparagus (cooked) 133  300g (approx. 20 spears) 
Spinach (cooked) 105  381g (approx. 4 cups) 
Orange 31  1300g(approx.12 oranges) 
Lentils (cooked) 182  220g (approx. 1 cup) 
Beef Liver 218  183g 
Multivitamin supplement 200-500 per capsule/tablet 1-2 capsules/tablets 
(Suitor and Bailey20, FSANZ24) 
 
Table 2: Classification of low and normal serum and erythrocyte folate levels 
 
Classification 
 
Serum folate 
(nmol/L) 
Erythrocyte folate 
(nmol/L) 
‘Very low’ 
 
<6.8 <370 
‘Moderately low’ 
 
6.8-<11.0 370-<513 
‘Normal’ 
 
>11.0 >513 
(Data from Flood et al.1) 
 
Figure 1: Absorbances for UVA and UVB radiation in 5MTHF and Folic Acid 
 
 
(Sourced from Steindal et al.46) 
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UVA penetrates to 
dermal circulation 
Oxidation of 
photosensitisers (ie. 
porphyrins and flavins) 
Direct absorption and
photodegradation of  
free folic acid in blood. 
Production of Reactive 
Oxygen Species (ROS) 
Formation of folic acid 
photoproducts ROS oxidize 5MTHF and form  
photoproducts 
Reduced folate blood 
levels 
Repletion of folate in 
skin by circulatory 
folate. 
Figure 2: Proposed pathway for blood folate degradation in human blood and 
skin 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sun Exposure 
(Ultraviolet radiation 
UVA and UVB) 
Skin  Direct and indirect 
photodegradation of 
folate in skin. 
Increased skin DNA 
damage if folate not 
repleted. 
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Table 3: Published in vivo studies in folate degradation and UV exposure 
 
 
 
 
Author 
(Country study conducted) 
Radiation treatment /cumulative 
dose (unless otherwise specified) 
Blood Testing protocol        Study participants          Results 
Gambichler et al.55
(Germany) 
 
UVA from sunbed twice weekly for 3 
weeks/96J cm2 
Serum folate tested with 
automated immunoassay 
 
N=24 healthy participants; n=8 
participants      randomised into UVA 
treatment group 
No significant differences in serum 
folate observed between exposed 
and non‐exposed groups. 
 
Shaheen et al. 59
(Egypt) 
 
Narrowband UVB  with 36 exposures/ 
76J/cm2 
Serum folate tested by HPLC  N=40 vitiligo patients ( n=20 study 
group; n=20 control) 
Significant decrease in serum folate 
following UV treatment (baseline 
18.3 + 5.9nmol/L vs. 13.4 + 
3.4nmol/L after UV). 
 
Fukuwatari et al.14
(Japan) 
 
Solar UV from outdoor exposure 
11.00‐13.00 for two days in summer/ 
UVA: 12 J/cm2 
Serum folate tested with 
microbioassay 
N=7 female students taking   0.25 mg 
of folic acid supplements at each 
meal for 2 days and morning of 
blood test.  
Control: same protocol and 
participants but no sun exposure on 
another day 
Significant decrease in serum folate 
following sun exposure (38.0 + 7.2 
nmol/L vs. 28.1 + 4.6 nmol/L). 
Rose et al. 57 
(United Kingdom) 
Narrowband UVB with minimum of 18 
exposures/UVB average 2.3 J cm2 per 
visit (Note: dose varied depending on 
participants clinical response to UVB 
phototherapy). 
 
Serum and erythrocyte tested 
with immunoassay 
N=35 psoriasis patients  No significant decreases in serum 
or erythrocyte folate following UVB 
exposure. 
Cicarma et al. 58
(Norway) 
 
Narrowband UVB from photocabinet 
with a total of 9‐15 treatments/ 2.35‐
13.4 J/cm2 (Note: dose varied 
depending on participants skin type 
and clinical response to UVB 
phototherapy). 
 
Serum and erythrocyte folate 
with immunoassay; 
25(OH)D with radioimmunoassay 
 
N=19 dermatological patients  Significant increase in 25(OH)D but 
no effect on blood folate status 
Juzienne et al.33
(Norway) 
Study 1 : Solar UV from outdoor 
exposure/UV not measured 
Study 2: UV from sunbed 4 sessions 2x 
10 min and 2 x 20min 
Study 3: Broadband UVB photocabinet 
single exposure/ UVB 0.18‐0.46 
J/cm2;UVA 0.04‐0.46 J/cm2 
Study 4: Broadband UVB photocabinet 
7‐22 exposures/ varied dose 
(maximum dose 115‐220J/cm2). 
Serum and erythrocyte folate; 
homocysteine and 25(OH)D 
Study 1: N=17 (4 psoriasis patients 
and 13 healthy participants). 
Study 2: N=6 healthy males 
Study 3: N=9 psoriasis patients 
Study 4: N=10 psoriasis patients 
No statistically significant effects of 
solar or artificial UV exposure on 
blood folates in all 4 studies. Slight 
reduction in blood folates reported 
in psoriasis patients. 
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